Showing 1 posts of 1 posts found.


FDA refuses Allergan’s uterine bleeding therapy with a request for more data

August 22, 2018
Research and Development, Sales and Marketing Allergan, Esmya, FDA, pharma

Allergan has shared the news that the FDA has refused to award marketing authorisation to its ulipristal acetate product Esmya …

Latest content